| Dr Victor Lewis, MD | |
|
151 Everett Ave, Chelsea Healthcare Center, Chelsea, MA 02150-1807 | |
| (617) 889-8580 | |
| (617) 889-8579 |
| Full Name | Dr Victor Lewis |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 151 Everett Ave, Chelsea, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376525725 | NPI | - | NPPES |
| J10324 | Other | MA | BCBS OF MA |
| 3067238 | Medicaid | MA | |
| 072924 | Other | MA | TUFTS HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 72924 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boston Health Care For The Homeless Program, Inc. | 2668475419 | 60 |
News Archive
Prana Biotechnology today announced that it has received approval from the Austin Health Human Research Ethics Committee (HREC) to commence a 12-month open label extension study with Alzheimer's Disease patients participating in Prana's IMAGINE trial.
One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.
In reviewing 25 years of U.S. malpractice claim payouts, Johns Hopkins researchers found that diagnostic errors — not surgical mistakes or medication overdoses — accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts.
Researchers at the University of Illinois Chicago have received more than $3.3 million to study the burden of tobacco use and to improve smoking cessation interventions for populations with demonstrated high smoking rates.
F2G Ltd and The University of Manchester Announce a new €6.1million project to develop new antifungal agents to treat resistant fungal infections.
› Verified 6 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Prana Biotechnology today announced that it has received approval from the Austin Health Human Research Ethics Committee (HREC) to commence a 12-month open label extension study with Alzheimer's Disease patients participating in Prana's IMAGINE trial.
One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.
In reviewing 25 years of U.S. malpractice claim payouts, Johns Hopkins researchers found that diagnostic errors — not surgical mistakes or medication overdoses — accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts.
Researchers at the University of Illinois Chicago have received more than $3.3 million to study the burden of tobacco use and to improve smoking cessation interventions for populations with demonstrated high smoking rates.
F2G Ltd and The University of Manchester Announce a new €6.1million project to develop new antifungal agents to treat resistant fungal infections.
› Verified 6 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Prana Biotechnology today announced that it has received approval from the Austin Health Human Research Ethics Committee (HREC) to commence a 12-month open label extension study with Alzheimer's Disease patients participating in Prana's IMAGINE trial.
One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.
In reviewing 25 years of U.S. malpractice claim payouts, Johns Hopkins researchers found that diagnostic errors — not surgical mistakes or medication overdoses — accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts.
Researchers at the University of Illinois Chicago have received more than $3.3 million to study the burden of tobacco use and to improve smoking cessation interventions for populations with demonstrated high smoking rates.
F2G Ltd and The University of Manchester Announce a new €6.1million project to develop new antifungal agents to treat resistant fungal infections.
› Verified 6 days ago
| Entity Name | Boston Health Care For The Homeless Program, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033157771 PECOS PAC ID: 2668475419 Enrollment ID: O20110527000309 |
News Archive
Prana Biotechnology today announced that it has received approval from the Austin Health Human Research Ethics Committee (HREC) to commence a 12-month open label extension study with Alzheimer's Disease patients participating in Prana's IMAGINE trial.
One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.
In reviewing 25 years of U.S. malpractice claim payouts, Johns Hopkins researchers found that diagnostic errors — not surgical mistakes or medication overdoses — accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts.
Researchers at the University of Illinois Chicago have received more than $3.3 million to study the burden of tobacco use and to improve smoking cessation interventions for populations with demonstrated high smoking rates.
F2G Ltd and The University of Manchester Announce a new €6.1million project to develop new antifungal agents to treat resistant fungal infections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victor Lewis, MD Po Box 9142, Mass. General Physician Organization, Charlestown, MA 02129-9142 Ph: (617) 889-8580 | Dr Victor Lewis, MD 151 Everett Ave, Chelsea Healthcare Center, Chelsea, MA 02150-1807 Ph: (617) 889-8580 |
News Archive
Prana Biotechnology today announced that it has received approval from the Austin Health Human Research Ethics Committee (HREC) to commence a 12-month open label extension study with Alzheimer's Disease patients participating in Prana's IMAGINE trial.
One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.
In reviewing 25 years of U.S. malpractice claim payouts, Johns Hopkins researchers found that diagnostic errors — not surgical mistakes or medication overdoses — accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts.
Researchers at the University of Illinois Chicago have received more than $3.3 million to study the burden of tobacco use and to improve smoking cessation interventions for populations with demonstrated high smoking rates.
F2G Ltd and The University of Manchester Announce a new €6.1million project to develop new antifungal agents to treat resistant fungal infections.
› Verified 6 days ago
Elena Volozhanina, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Broadway, Chelsea, MA 02150 Phone: 617-975-6200 Fax: 617-975-6151 | |
Mercedes Freije Ibanez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Broadway, Chelsea, MA 02150 Phone: 617-975-6200 | |
Faiz Khan, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 151 Everett Ave, Chelsea, MA 02150 Phone: 617-884-8300 | |
Jessica A Zeidman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 151 Everett Avenue, Chelsea Healthcare Center, Chelsea, MA 02150 Phone: 617-889-8580 Fax: 617-889-8579 | |
Dr. Jose Antonio Abrego, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Broadway, Chelsea, MA 02150 Phone: 617-975-6200 Fax: 617-975-6151 | |
Arshia Siddiqui, M.D., MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 151 Everett Ave, Chelsea, MA 02150 Phone: 617-884-8300 |